Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia Lemoine

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease casesMona-Lisa Malarte, Agneta Nordberg, Laetitia Lemoine
European Journal of Medicinal Chemistry|May 31, 2011
Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracersJulien Andries, Laetitia Lemoine, Didier Le Bars, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target bindingLaetitia Lemoine, Antoine Leuzy, Konstantinos Chiotis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2011
Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracerLaetitia Lemoine, Julien Andries, Didier Le Bars, et al.
Scientific Reports|April 5, 2017
Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by <sup>3</sup>H-THK5117 and <sup>3</sup>H-deprenyl autoradiographyLaetitia Lemoine, Laure Saint-Aubert, Inger Nennesmo, et al.
Global Health, Science and Practice|December 22, 2021
Leveraging the Client-Provider Interaction to Address Contraceptive Discontinuation: A Scoping Review of the Evidence That Links ThemKendal Danna, Alexandra Angel, Jamee Kuznicki, et al.
Nuclear Medicine and Biology|July 17, 2013
Characterization of FlipIDAM as a SERT-selective SPECT imaging agentLaetitia Lemoine, Brian P Lieberman, Karl Ploessl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2019
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imagingN Arul Murugan, Konstantinos Chiotis, Elena Rodriguez-Vieitez, et al.
Molecular Neurodegeneration|February 22, 2017
Tau PET imaging: present and future directionsLaure Saint-Aubert, Laetitia Lemoine, Konstantinos Chiotis, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanolPinguan Zheng, Brian P Lieberman, Karl Ploessl, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease casesMona-Lisa Malarte, Agneta Nordberg, Laetitia Lemoine
European Journal of Medicinal Chemistry|May 31, 2011
Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracersJulien Andries, Laetitia Lemoine, Didier Le Bars, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target bindingLaetitia Lemoine, Antoine Leuzy, Konstantinos Chiotis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2011
Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracerLaetitia Lemoine, Julien Andries, Didier Le Bars, et al.
Scientific Reports|April 5, 2017
Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by <sup>3</sup>H-THK5117 and <sup>3</sup>H-deprenyl autoradiographyLaetitia Lemoine, Laure Saint-Aubert, Inger Nennesmo, et al.
Global Health, Science and Practice|December 22, 2021
Leveraging the Client-Provider Interaction to Address Contraceptive Discontinuation: A Scoping Review of the Evidence That Links ThemKendal Danna, Alexandra Angel, Jamee Kuznicki, et al.
Nuclear Medicine and Biology|July 17, 2013
Characterization of FlipIDAM as a SERT-selective SPECT imaging agentLaetitia Lemoine, Brian P Lieberman, Karl Ploessl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2019
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imagingN Arul Murugan, Konstantinos Chiotis, Elena Rodriguez-Vieitez, et al.
Molecular Neurodegeneration|February 22, 2017
Tau PET imaging: present and future directionsLaure Saint-Aubert, Laetitia Lemoine, Konstantinos Chiotis, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanolPinguan Zheng, Brian P Lieberman, Karl Ploessl, et al.
Pageof 3